CEO SUMMARY: Automated cytology technology received a big boost when the FDAās advisory panel voted to recommend that the FDA approve, with conditions, NeoPathās AutoPapĀ® System as a primary Pap Smear Screener. The company still awaits final FDA approval on this matter. ON JANUARY 28, the Food And Drug Administrationās (FDA) Hematology and Pathology Devices […]
To access this post, you must purchase The Dark Report.